Skip to main content
Karina Eterovic, PhD

SelectScience Editorial Article: Routine germline sequencing aids decision-making in cancer care

In an exclusive interview, study author Dr. Karina Eterovic, R&D Director of Oncology Diagnostics at Eurofins Viracor Biopharma Services, discusses the complex interplay between clonal hematopoiesis and cancer genomics, in the context of precision of cancer diagnosis and treatment.

Germline sequencing provides crucial insights into clonal hematopoiesis mutations with the potential to improve cancer patient outcomes and new oncology therapy development


Click here to read the full article.

Back to top